Why is Emmessar Biotech falling/rising?

As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.05, reflecting a slight increase of 0.05, or 0.16%. The stock has been gaining for the last two days, with a total return of 3.53% during this period. However, it has underperformed its sector by 0.92% today. In terms of longer-term performance, the stock has experienced a decline of 1.43% over the past month and a significant drop of 32.94% year-to-date. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 405.63% compared to the 5-day average, indicating growing interest in the stock.
In the broader market context, the Sensex has outperformed Emmessar Biotech, returning 1.21% over the past week and 2.38% over the past month, while the stock has seen negative returns in both timeframes. Year-to-date, the Sensex has gained 8.10%, contrasting sharply with Emmessar's 32.94% decline. This disparity suggests that while the stock is currently experiencing a minor uptick, it remains under pressure compared to the overall market performance. The stock's moving averages indicate it is performing better than its 5-day and 20-day averages but still lags behind the longer-term averages, reflecting a mixed outlook in the context of broader market trends.